Strand’s novel virtual liver to replace some animal experiments
Strand Life Sciences, a technology innovation major, has developed a computer simulated virtual liver to predict and explain mechanisms of drug-induced hepatotoxicity. The virtual liver, which was created using a mathematical model of a normal liver physiology of a rat, can now be used to assess the toxicity of drug molecules. The virtual liver requires some input parameters related to metabolic rates that are measured for each drug molecule using assays on rat liver cells.http://www.pharmabiz.com/NewsDetails.aspx?aid=64408&sid=1
